Literature DB >> 21892095

Routine hysterectomy in the surgical management of ovarian cancer: a retrospective case series, physician opinion survey, and review of the literature.

Michael W Bunting1, Ken S Jaaback, Orla M McNally.   

Abstract

Current international guidelines recommend routine hysterectomy in the initial surgical management of epithelial ovarian cancer. However, there seems to be limited evidence to support these recommendations. We examined the data for a series of women undergoing hysterectomy as part of surgical management of ovarian cancer. Most of the women who underwent hysterectomy had no macroscopic uterine involvement in the ovarian cancer. However, almost half of them had macroscopic residual disease at completion of cytoreductive surgery. The incidence of synchronous primary endometrial cancers was 5%, and preoperative ultrasound had a sensitivity of 82% for predicting endometrial pathology. We also surveyed the members of the Australian Society of Gynaecological Oncologists (ASGO) regarding the role of hysterectomy in the management of ovarian cancer. Most of the respondents indicated that they believe hysterectomy should be routinely performed in the management of ovarian cancer but acknowledge that there is a lack of evidence to support the practice.

Entities:  

Mesh:

Year:  2011        PMID: 21892095     DOI: 10.1097/IGC.0b013e318227c9ac

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  2 in total

1.  Pathologic distribution at the time of interval tumor reductive surgery informs personalized surgery for high-grade ovarian cancer.

Authors:  Courtney D Bailey; Rebecca Previs; Bryan M Fellman; Tarrik Zaid; Marilyn Huang; Alaina Brown; Ahmed Enbaya; Nyla Balakrishnan; Russell R Broaddus; Diane C Bodurka; Pamela Soliman; Nicole D Fleming; Alpa Nick; Anil K Sood; Shannon Neville Westin
Journal:  Int J Gynecol Cancer       Date:  2020-10-29       Impact factor: 3.437

2.  Uterine involvement in epithelial ovarian cancer and its risk factors.

Authors:  Narges Zamani; Azam Sadat Mousavi; Setare Akhavan; Shahrzad Sheikhhasani; Somayeh Nikfar; Elham Feizabad; Elahe Rezayof; Mitra Modares Gilani
Journal:  J Ovarian Res       Date:  2021-12-07       Impact factor: 4.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.